Pacer Advisors’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,376
| Closed | -$52.8K | – | 2543 |
|
|
2024
Q2 | $52.8K | Buy |
1,376
+684
| +99% | +$26.2K | ﹤0.01% | 3109 |
|
|
2024
Q1 | $40.7K | Buy |
+692
| New | +$40.7K | ﹤0.01% | 3255 |
|
|
2021
Q2 | – | Sell |
-1,669
| Closed | -$72K | – | 1416 |
|
|
2021
Q1 | $72K | Sell |
1,669
-986
| -37% | -$42.5K | ﹤0.01% | 1359 |
|
|
2020
Q4 | $152K | Sell |
2,655
-736
| -22% | -$42.1K | ﹤0.01% | 1279 |
|
|
2020
Q3 | $102K | Buy |
+3,391
| New | +$102K | ﹤0.01% | 1246 |
|
|
2018
Q4 | – | Sell |
-2,602
| Closed | -$46K | – | 558 |
|
|
2018
Q3 | $46K | Buy |
+2,602
| New | +$46K | ﹤0.01% | 1147 |
|